Table 2.
Iron requirements and treatment received, overall and by diagnosis in the analysis population
| IDA (n = 114) |
IDNA (n = 205) |
Overall (n = 319) |
|
|---|---|---|---|
| Iron requirement | |||
| Physician-calculated,a mg, mean (SD) | 1077.5 (337.9) | 965.5 (229.5) | 1005.5 (277.9) |
| Calculated for this study,b mg, mean (SD) | 1381.0 (350.3) | 1189.7 (243.3) | 1256.7 (299.0) |
| FDI treatment | |||
| Dose, mg, mean (SD) | 941.2 (252.0) | 881.0 (248.3) | 902.5 (250.9) |
| Mode of administration, n (%) | |||
| Bolus injection | 8 (7.0) | 28 (13.7) | 36 (11.3) |
| Infusion | 106 (93.0) | 177 (86.3) | 283 (88.7) |
| Duration of infusion, min, mean (SD) | 36.6 (17.6) | 37.7 (16.2) | 37.3 (16.7) |
FDI ferric derisomaltose, IDA iron deficiency anemia, IDNA iron deficiency without anemia, SD standard deviation, SmPC summary of product characteristics
aCalculated based on the simplified dosing table or the Ganzoni formula provided in the Swiss SmPC for FDI, or based on a fixed dose
bCalculated based on the simplified dosing table provided in the Swiss SmPC for FDI